- Home
- INBK vs NVCT Comparison
INBK vs NVCT Comparison
Compare INBK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- NVCT
- Stock Information
- Founded
- INBK 1999
- NVCT 2020
- Country
- INBK United States
- NVCT United States
- Employees
- INBK N/A
- NVCT N/A
- Industry
- INBK Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- INBK Finance
- NVCT Health Care
- Exchange
- INBK Nasdaq
- NVCT Nasdaq
- Market Cap
- INBK 191.0M
- NVCT 167.0M
- IPO Year
- INBK N/A
- NVCT 2022
- Fundamental
- Price
- INBK $24.10
- NVCT $6.19
- Analyst Decision
- INBK Hold
- NVCT Strong Buy
- Analyst Count
- INBK 3
- NVCT 3
- Target Price
- INBK $30.67
- NVCT $15.33
- AVG Volume (30 Days)
- INBK 32.6K
- NVCT 60.0K
- Earning Date
- INBK 10-22-2025
- NVCT 11-04-2025
- Dividend Yield
- INBK 1.01%
- NVCT N/A
- EPS Growth
- INBK N/A
- NVCT N/A
- EPS
- INBK 1.76
- NVCT N/A
- Revenue
- INBK $106,219,000.00
- NVCT N/A
- Revenue This Year
- INBK $5.27
- NVCT N/A
- Revenue Next Year
- INBK $27.40
- NVCT N/A
- P/E Ratio
- INBK $13.56
- NVCT N/A
- Revenue Growth
- INBK 4.74
- NVCT N/A
- 52 Week Low
- INBK $19.54
- NVCT $4.44
- 52 Week High
- INBK $43.27
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- INBK 48.34
- NVCT 42.49
- Support Level
- INBK $23.52
- NVCT $6.15
- Resistance Level
- INBK $24.67
- NVCT $6.61
- Average True Range (ATR)
- INBK 0.77
- NVCT 0.27
- MACD
- INBK -0.07
- NVCT 0.01
- Stochastic Oscillator
- INBK 30.47
- NVCT 5.48
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.